All In Biotech

Drug Trial Radar · NCT04748796

Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility

Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility: an Open Label Prospective Randomized Study

Last checked: Nov 21, 2026Latest source record: Aug 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 360 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

360

Planned (sponsor's estimate)

Start

Feb 1, 2021

Primary completion

Jun 2027

Study completion Sep 2027

Sponsor

Lead sponsor
Centre Hospitalier Universitaire, AmiensAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
CH Dieppe; CH Elbeuf; CH Le Havre; Centre Hospitalier de Beauvais; Centre Hospitalier Intercommunal de Compiègne-Noyon; CH Laon; University Hospital, Caen; CH Cherbourg; University Hospital, Lille; CH Douai; CH Montreuil; Centre Hospitalier de Roubaix; Centre Hospitalier de Bethune; CH Lomme; Centre Hospitalier de Lens; Tourcoing Hospital; Centre Hospitalier VALENCIENNES; Centre Hospitalier Arras; Hospital Ambroise Paré Paris; University Hospital, Brest; Henri Mondor University Hospital; Hospital Avicenne; University Hospital, Montpellier; CH Calais; Hôpital Edouard Herriot; Centre Hospitalier Universitaire de Nīmes; Groupe Hospitalier Pitie-Salpetriere; Hôpital Louis Mourier, Colombes
First posted
Feb 10, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Several data emphasize the relation between tachycardia (\>90/min) and high mortality during septic shock. The investigators previously demonstrated the high mortality associated with hypercontractility, tachycardia and the presence of a left ventricular obstruction. A severe hypovolemia, a hyper adrenergic stimulation or a severe vasoplegia can all explain this relation between tachycardia, hypercontractility and the mortality during septic shock. Landiolol is another short-term acting beta-blocker with a half-life of 4 minutes without any beta 2 activity or membrane stabilizing effect. The landiolol has been used in critically ill patients to control supraventricular tachycardia but not in this context of tachycardia and septic shock. The investigators hypothesize that landiolol by reducing the heart rate may improve the survival of patients treated for a septic shock and presenting with an hypercontractility state.

Conditions

  • Septic Shock
  • Tachycardia
  • Mortality During Septic Shock
  • Beta-blocker

Interventions

  • echocardiographyOther

    Full echocardiography will be performed at baseline and during the follow-up at H1, H3, H6 and H12.

  • LandiololDrug

    Patients randomized to the experimental group will be treated according to the standard of care plus for 2 days with landiolol IV started at a dose of 1 microgram/kg/min and progressively increased every 10 minutes to a maximum of 40 micrograms/kg/min.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Variation of mortality rate in landiolol group compared to control groupTime frame: day 28

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • CHU Amiens

    Amiens, France · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.